Should glucagon‐like peptide‐1 receptor agonist treatment be withheld in preoperative management?

The time‐varying cardiovascular benefits of glucagon‐like peptide‐1 receptor agonist therapy in patients with type 2 diabetes mellitus: Evidence from large multinational trials

(2022) Salil V. Deo et al.   DIABETES OBESITY & METABOLISM

Normal and disordered gastric emptying in diabetes: recent insights into (patho)physiology, management and impact on glycaemic control

(2022) Ryan J. Jalleh et al.   DIABETOLOGIA

Semaglutide delays 4‐hour gastric emptying in women with polycystic ovary syndrome and obesity

(2022) Mojca Jensterle et al.   DIABETES OBESITY & METABOLISM

Effect of A1C and Glucose on Postoperative Mortality in Noncardiac and Cardiac Surgeries

(2018) Willem van den Boom et al.   DIABETES CARE

Basal insulin or longacting GLP-1 receptor agonists—making the right choice

(2014) Zachary T Bloomgarden   Lancet Diabetes & Endocrinology

Elevated preoperative hemoglobin A1c level is predictive of adverse events after coronary artery bypass surgery

(2008) Michael E. Halkos et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY